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Microglia form the immune system of the brain. Previous studies in cell cultures and animal models
suggest altered activation states and cellular senescence in the aged brain. Instead, we analyzed 3
transcriptome data sets from the postmortem frontal cortex of 381 control individuals to show that
microglia gene markers assemble into a transcriptional module in a gene coexpression network. These
markers predominantly represented M1 and M1/M2b activation phenotypes. Expression of genes in this
module generally declines over the adult life span. This decrease was more pronounced in microglia
surface receptors for microglia and/or neuron crosstalk than in markers for activation state phenotypes.
In addition to these receptors for exogenous signals, microglia are controlled by brain-expressed regu-
latory factors. We identiﬁed a subnetwork of transcription factors, including RUNX1, IRF8, PU.1, and TAL1,
which are master regulators (MRs) for the age-dependent microglia module. The causal contributions of
these MRs on the microglia module were veriﬁed using publicly available ChIP-Seq data. Interactions of
these key MRs were preserved in a protein-protein interaction network. Importantly, these MRs appear
to be essential for regulating microglia homeostasis in the adult human frontal cortex in addition to their
crucial roles in hematopoiesis and myeloid cell-fate decisions during embryogenesis.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The human brain’s transcriptome varies over its life span and
drastically changes at speciﬁc developmental stages, such as at the
time of birth and by the end of infancy or childhood (Colantuoni
et al., 2011; Kang et al., 2011) or in response to insults or in-
juries (Hashimoto-Torii et al., 2011; Rosell et al., 2011; VanGilder
et al., 2012). In any cell type transcription rate variation allows
adaptation to changing environments (Li et al., 2013; Somel et al.,
2013) and therefore plays a crucial role in healthy aging or path-
ogenesis (Courtney et al., 2010; Miller et al., 2010; Mills and Janitz,
2012; Ponomarev et al., 2012; Twine et al., 2011; Vidal et al., 2011).
Different cell types and functionally related genes co-ordinate
their transcriptional patterns, reﬂecting the regulatory crosstalk
among interacting genes (Konopka et al., 2012; Langfelder and
Horvath, 2008; Oldham et al., 2008). A previous network anal-
ysis of the human brain’s transcriptome from fetal to old ageogy, Anatomy and Genetics,
3QX, UK. Tel.: þ44 (0)1865
(C.C. Wehrspaun).
Inc. This is an open access articledetected transcriptional modules of co-expressed genes that are
distinguished mostly by strong fold changes in expression before
and after birth and during early childhood (Kang et al., 2011).
However, it is less clear how age affects gene modules during the
more subtle gene expression changes in later life (Colantuoni et al.,
2011; Kang et al., 2011). Identiﬁcation of age-dependent gene
modules in adulthood could improve our understanding of periods
that are critical for brain plasticity or for susceptibility to late-
onset diseases.
Fine tuning of expression dynamics depends on key regulatory
elements for transcription initiation. Transcription factors (TFs)
recognize binding motifs in the vicinity of their target genes and
control temporal expression patterns (Birney et al., 2007;
Wasserman and Sandelin, 2004). The complete set of genes regu-
lated by a given TF is deﬁned as its “regulon”. TFs are highly diverse
in their binding patterns and regulon sizes and consequentially in
the extent of their potential downstream inﬂuence (Wasserman
and Sandelin, 2004). A module that is regulated by a TF acting as
a master regulator (MR) shows signiﬁcant overlap between its
genes and the TF’s regulon (Carro et al., 2010). The identiﬁcation of
MRs in TF cascades is central to understanding the key components
underlying transitions between different physiological statesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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example, PU.1, RUNX1, and TAL1 act as MRs for hematopoiesis and
microglia genesis during embryonic development (Lichtinger et al.,
2012). Transcriptional modules have been identiﬁed in the human
brain’s transcriptome based on their link to Alzheimer’s disease
(Forabosco et al., 2013; Zhang et al., 2013). However, it remains
poorly understood which MRs co-ordinate these modules’ expres-
sion during healthy aging. Importantly, elucidating regulatory
patterns for microglia gene expression allows the identiﬁcation of
developmental stages that are critical to disease susceptibility.
Microglia form the innate immune system of the central nervous
system (CNS) (David and Kroner, 2011; Norden and Godbout, 2013).
They play a fundamental role in healthy and pathological aging
(Paolicelli et al., 2011; Schuitemaker et al., 2012), undergoing major
morphological changes with increasing age (Conde and Streit,
2006; Hefendehl et al., 2014; Streit et al., 2004) while maintain-
ing cell numbers (Long et al., 1998; Norden and Godbout, 2013;
VanGuilder et al., 2011). Transition between their phenotypical
activation states, M1 and M2, has been linked to various disease
pathways (Appel et al., 2010; Kumar et al., 2013; Liao et al., 2012).
M1 reﬂects the classically activated stage and might contribute to
neurotoxicity (Kumar et al., 2013) induced by interferon gamma
and toll-like receptor (TLR) agonists (Saijo and Glass, 2011), as
opposed to a continuum of alternative activated M2 states involved
in tissue repair (Lampron et al., 2011). M2a cells are induced by IL-4
or IL-13, M2b are induced by immune complexes and TLR agonists,
and M2c are induced by IL-10 or transforming growth factor (Appel
et al., 2010). Animal studies suggest that during aging M1 pheno-
types increase, accompanied by a decrease in M2 (Lee et al., 2013).
Microglia are key factors for communication between the CNS and
the peripheral immune system (Norden and Godbout, 2013), by
crosstalking to T-cells (Appel et al., 2010) and by modulating the
permeability of the blood-brain barrier (Nishioku et al., 2010; Sumi
et al., 2010). During early development, microglia emerge from
hematopoietic progenitors in the yolk sac (Ginhoux et al., 2010).
Injuries may induce a second wave of hematopoiesis during
adulthood and after inﬁltration of CNS by bone marrowederived
myeloid cells (Lampron et al., 2011; Ponomarev et al., 2013).
Microglia from both origins share a dependence on critical TFs, such
as PU.1 (SPI1) (Ponomarev et al., 2013) which is expressed in the
human adult brain (Smith et al., 2013). The microglia response to
insults is reﬂected by dynamic transitions between M1 and M2
phenotypes (Aguzzi et al., 2013) which are mediated via intrinsic
(e.g., RUNX1, IRF8, and PU.1) and extrinsic factors interacting with
microglia receptors (e.g., CD200, CX3CR1, and TREM2) (Kierdorf and
Prinz, 2013).
We sought to identify TFs that act as MRs for age-dependent
modules within the context of the healthy human postmortem
brain. The intact brain environment, including all cell types, is
essential for understanding the microglia regulatory network dur-
ing aging as it evolves in close communication with other cells, for
example, neurons (Kierdorf and Prinz, 2013) and the peripheral
immune system (Norden and Godbout, 2013). To detect these key
regulatory networks in the aging brain, we applied an unbiased
data driven approach which ﬁrst detected modules whose repre-
sentative expression pattern is correlated with aging and then
predicted TFs acting as MRs for these modules. Combining 2 ap-
proaches for network analysis, we identiﬁed a microglia module
whose expression pattern was negatively correlated with age,
especially for those genes that encode microglia surface receptors
for neuron and/or microglia crosstalk. This microglia module in the
healthy adult brain was found to be regulated by a set of hemato-
poietic MRs, including TFs known to act as endogenous factors
regulating microglia activation or cell differentiation during em-
bryonic development (Kierdorf and Prinz, 2013; Prinz and Priller,2014), such as RUNX1, IRF8, PU.1, and TAL1. These MRs, thus, play
key roles not only during early development but also in microglia
cell homeostasis in the human adult brain.
2. Methods
2.1. Microarray gene expression
Microarray gene expression data from healthy human controls
from 3 independent data sets were used to generate transcriptional
networks. In all cases, we averagedmultiple probes available for the
same annotated gene.
2.1.1. Braincloud
All microarray expression data from the prefrontal cortex were
quantiﬁed per gene (log2[sample/reference]) as relative gene
expression and processed as described previously (Colantuoni et al.,
2011). The RNA was analyzed using 2-color custom-spotted oligo-
nucleotidemicroarrays from the National HumanGenome Research
Institute microarray core facility using the Illumina Oligoset
(HEEBO7) of 49,152 70-mer probes (Colantuoni et al., 2011). We
included n ¼ 184 subjects, aged 12.9e78.2 years. If multiple probes
were available for 1 gene, we calculated the average expression for
this gene, resulting in a total of n ¼ 18,846 available genes
(GSE30272). The representative expression patterns of the tran-
scriptional modules were tested for correlation with the available
confounding variables RNA integrity number (RIN), pH, and post-
mortem interval (PMI).
2.1.2. Medical Research Council sudden death brain and tissue bank
If multiple probes were available for 1 gene, we calculated the
average expression for this gene, resulting in a total of n ¼ 21,513
probes from frontal cortex of n ¼ 97 subjects, aged between 16 to
83 years (available from GSE46706 using Affymetrix Human Exon
1.0 ST Array) (Millar et al., 2007, Trabzuni et al., 2011). Background
correction and array preprocessing were performed using multi-
array average quantile normalization. Quantile normalization is a
part of the robust multiarray average expression summary measure
and aims to normalize a batch of arrays to allow for meaningful
comparisons. The representative expression patterns of the tran-
scriptional modules were tested for correlation with the only
available confounding variable, PMI.
2.1.3. Harvard brain tissue resource center
Gene expression data from the dorsolateral prefrontal cortex of
n ¼ 100 healthy subjects between 50 and 95 years were included
(GSE44770 using Rosetta/Merck Human 44k 1.1 microarray) (Zhang
et al., 2013). N ¼ 14,400 probes with annotated gene names were
used of n ¼ 30,305 available probes. Expression was quantiﬁed as
log2(sample/reference) as relative gene expression.
2.2. ChIP-Seq data
We used publicly available ChIP-Seq data to validate TF targets. If
available, we annotated peaks from cell lines provided by ENCODE
(Birney et al., 2007); alternatively we searched for ChIP-Seq data for
MRs described in the literature. The publicly available data provided
ChIP-Seq peak sets. All peaks were annotated using HOMER [v4.3
(Heinz et al., 2010)]. (1) For PU.1 (SPI1), we used broad ChIP-Seq
peaks from 3 cell lines in the ENCODE data: GM12878 (B-lympho-
cyte, lymphoblastoid; 42,935 peaks), GM12891 (B-lymphocyte,
lymphoblastoid; 48,830 peaks), and K562 (leukemia; 28,677 peaks).
(2) RUNX1 peaks were annotated from peripheral blood mono-
nuclear cells CD34þ and transferred from build hg18 to hg19 using
the online liftOver tool [PBMNC CD34þ; sample GSM722708
C.C. Wehrspaun et al. / Neurobiology of Aging 36 (2015) 2443.e9e2443.e20 2443.e11(Ptasinska et al., 2012); 14,536 peaks], and from cell line CUTLL1
(T lymphoblastic leukemia and/or lymphoma cell line; sample
GSM1252931; 28,156 peaks) (3) IRF8 ChiP-Seq peaks were retrieved
from human germinal center B cells (LY1 cell lines).We included only
peaks in IRF8-target genes which were replicated across all cell lines
used in the original study (183 peaks) (Shin et al., 2011). Peaks were
transferred from build hg18 to hg19 using the online liftOver tool
(part of the UCSC Genome Browser). (4) ChiP-Seq peaks from K562
cell ENCODE data from 2 replicates were used for TAL1 (26,255 and
54,782 narrow peaks). In addition, we used genomic regions occu-
pied by TAL1 in 4 other cell lines: Jurkat, CCRF-CEM (human T cell
lymphoblast-like cell line), and PrimaGRAFT (Prima 2 and Prima 5,
derived from primary T-ALL cells in immunocompromised mice and
mapped to hg18) (Sanda et al., 2012) (19,844 occupied regions). The
co-ordinates of the occupied regions were transferred from genome-
build hg18 to hg19 using the online liftOver tool. (5) For NANOG, we
used narrow peaks (n ¼ 5473) from cell line H1-hESC (human em-
bryonic stem cells) from the ENCODE data.
2.3. Weighted correlation network analysis
Coexpression networks were built using step-by-step network
construction and module detection as implemented in WGCNA
[Weighted correlation network analysis (Langfelder and Horvath,
2008)]. Brieﬂy, in the ﬁrst step a pairwise Pearson’s correlation
matrix of all genes across all time points was calculated. This cor-
relation matrix was then converted into an adjacency matrix. The
soft thresholding power was chosen to reach a scale-free topology
ﬁt index indicating approximate scale-free topology, as suggested
by the authors (Langfelder and Horvath, 2008). Next, the adjacency
matrix was transformed to a topological overlap matrix, thereby
reducing spurious associations, and a dissimilarity matrix was
calculated, which was then used to produce a hierarchical tree. The
minimum cluster size was arbitrarily set to 10 genes. The standard
method for branch cutting, namely Dynamic Tree Cut, was applied
(Langfelder and Horvath, 2008). This function returns gene mod-
ules, each of which is assigned a color. To reduce redundant infor-
mation, modules with highly similar expression proﬁles were
merged. This merging procedure was applied using a height cut of
0.25 (corresponding to a correlation of 0.75). Merging was based on
the comparison of the module eigengenes which provides a sum-
mary expression metric. These module eigengenes were also
correlated with any external quantitative trait to analyze the de-
pendency between the given trait and the module’s expression.
Here, we used age and 3 potential confounding variables (RIN, pH,
and PMI). More speciﬁcally, we selected modules whose eigengene
was correlated with age at more signiﬁcant p-values than for
available confounding variables. For each available confounding
variable, we further tested for Pearson’s correlation between age
and module eigengene after matching the samples for the available
confounding variables. The matching procedure consisted in ﬁrst
selecting samples with the same value for a confounding variable,
and subsequently testing for correlation of the module eigengene
using these samples only. The transcriptional networks were un-
directed, or in other words did not contain information on edge
orientation. Similar results were found, however, for directed net-
works (data not shown).
2.4. ARACNE
Algorithm for the Reconstruction of Accurate Cellular Networks
(ARACNE) uses mutual information (MI) to reconstruct transcrip-
tional networks and permits the prediction of TF targets (Basso
et al., 2005; Margolin et al., 2006a, 2006b). Reverse engineering
yields a scale-free hierarchical gene-gene coexpression network(Basso et al., 2005). Brieﬂy, “scale-free” refers to a network with a
small number of major hub genes. Importantly, ARACNE takes an
unbiased approach which uses the full dynamic range of the data
without assuming the underlying network topology (Margolin
et al., 2006b). The construction of a network from genome-wide
expression data is based on the deﬁnition of statistical de-
pendencies between all variables, such as expression time courses.
ARACNE estimates MI using a Gaussian kernel as described further
in (Margolin et al., 2006a). Redundant network edges are pruned
using data processing inequality (DPI). DPI tests each gene triplet,
irrespectively of whether edges in this triplet have been examined
before, and removes edges with the lowest MI. How many triplets
are broken depends on the chosen DPI tolerance, ranging from 0,
where all triplets are broken on the weakest link, to 1 which pre-
serves all triplets; recommended values are between 0 and 0.15
(Margolin et al., 2006b); here we applied 0.1. If a list of known TFs is
provided as a prior, putative TF-target connections are protected in
such a way that edges between a given TF and its target cannot be
eliminated in favor of edges between 2 nonTFs (Margolin et al.,
2006b). We provided a list of n ¼ 2001 TFs previously described
in Vaquerizas et al. (2009) and Wingender et al. (2013). ARACNE
converts a user-provided p-value to an MI threshold [p-value ¼
107 (Margolin et al., 2006a, 2006b)]. Subsequently, ARACNE re-
ports only MI values that are more signiﬁcant than this threshold,
which represents a probability of 107 to obtain an MI score greater
or equal to the calculated threshold by chance if the expression
levels of 2 genes vary independently of each other (Margolin et al.,
2006b). As suggested by the authors (Margolin et al., 2006b), we
generated a consensus bootstrapping network using n ¼ 100
sampling steps.
2.5. MR analysis
To identify TFs acting as MRs, we predicted the regulon (in other
words the target genes) of each TF using ARACNE. Next, we used
Fisher’s exact test (FET) to calculate whether the intersection of the
age-dependent coexpression module with each TF’s regulon was
larger than expected by chance (a < 0.05, corrected in each data set
for the number of TFs that were included in the transcriptional
network constructed by ARACNE). More precisely, the contingency
table for the FET contained genes in the module (yes and/or no)
versus genes in the TF’s regulon (yes and/or no). TFs whose regulon
shared a higher number of genes with the age-dependent module
than expected by chance were termed “master regulators” for the
age-dependent module.
2.6. Enrichment of functional categories and cell types
Enrichment was assessed using Gene Ontology (GO)eterms and
Kyoto Encyclopedia of Genes and Genomes (KEGG)-pathways
comparing the genes in the microglia module against a background
of all genes in the WGCNA network using the functional classiﬁ-
cation tool Database for Annotation, Visualization, and Integrated
Discovery (Huang et al., 2009) and Genomic Regions Enrichment of
Annotations Tool [GREAT version 2.0.2 (McLean et al., 2010)].
Brieﬂy, GREAT assigns “basal regulatory domains” as deﬁned by
McLean et al. (2010) to the genomic regions of interest, spanning 5
kb upstream to 1 kb downstream of the transcription start site (TSS)
of the nearest gene relative to the regions provided in the input,
plus a distal extension of up to 1000 kb or up to the next nearest
gene’s basal regulatory domain in both orientations. We included
GO-terms from the analysis using GREAT with a signiﬁcant q-value
(a < 0.05, hypergeometric p-value, corrected for multiple testing
using false discovery rate [FDR]) and KEGG-pathways in Database
for Annotation, Visualization, and Integrated Discovery with a
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contributing to the age-dependent module for all 3 data sets
combined (n ¼ 407 basic regulatory domains available in ENSEMBL
BioMart) were compared with a background of all genes with an-
notated gene names and basal regulatory regions in all 3 data sets
(n ¼ 19,045). Similar results were found when enrichment was
tested separately for each of the 3 data sets. The underlying cell
population of the age-dependent gene coexpression module was
tested by comparing the number of expressedmicroglial markers in
the module combined for all 3 data sets to the number of expressed
microglial markers in n ¼ 1000 random gene sets of the same
sample set size using the genes available in all 3 microarrays
combined as a background. For testing enrichment of the named
ontologies for MRs (n ¼ 107, united for all 3 data sets), we used all
genes with annotated gene names and basal regulatory regions in
all 3 data sets as a background (n ¼ 19,045 genomic regions).
2.7. Disease Association Protein-Protein Link Evaluator
DAPPLE (Disease Association Protein-Protein Link Evaluator)
takes as input a list of genes (here 107 MRs) and searches for
physical connectivity between proteins based on protein-protein
interactions known from the literature. DAPPLE assesses p-values
for direct and indirect interactions using n ¼ 1000 within-degree
node-label permutations (Rossin et al., 2011). “Degree” of a node
refers to the number of edges directly connected to the node. An
empirical p-value is calculated for each node as the number of
random permutations which yield a degree for the node which is as
high as or higher than the observed node degree, divided by the
total number of permutations (Rossin et al., 2011).
2.8. Intersection of genomic intervals
We used the GAT (Genomic Association Tester) tool (Heger et al.,
2013) to test for a signiﬁcant intersection between the basal regu-
latory regions (5 kb upstream to 1 kb downstream of the TSS) of theFig. 1. Venn diagram showing the overlap of genes in the 3 microarray gene expression data
expression data sets braincloud, Medical Research Council (MRC/UK) and Harvard Brain Tissu
diagram showing the age-dependent modules and their gene overlaps.genes in the age-dependent module and the ChIP-Seq peaks for the
TFs that were identiﬁed as MRs for the age-dependent module. GAT
calculates the intersection of 2 sets of genomic intervals while
controlling for different potential confounders such as varying G þ
C content or differences among chromosomes (Heger et al., 2013). It
assigns a p-value based on a randomization simulation procedure
within the providedworkspaceepotentially thewhole genome, or a
pruned background. Here, we used the basal regulatory regions of
all 3 gene expression data sets that were used to build the tran-
scriptional networks. More precisely, GAT takes the 2 sets of in-
terest, for example, ChIP-Seq peaks and the co-ordinates for genes
of interest, and compares their overlap to randomly chosen sets of
intervals across the workspace. Multiple testing correction was
applied using Storey’s q-value (Storey and Tibshirani, 2003) or
Benjamini-Hochberg correction (Benjamini et al., 2001) by an false
discovery rate procedure (Heger et al., 2013).3. Results
3.1. An age-dependent gene module in frontal cortex is preserved
across independent data sets
Three independent microarray gene expression data sets from
healthy human postmortem frontal cortex tissue (Fig. 1AeB) were
used to generate transcriptional networks across the life span using
WGCNA (Langfelder and Horvath, 2008). Genes whose expression is
distinctive of cell types and/or are functionally related are expected
to show higher co-ordination of expression and thus can be
assembled by this analysis into gene modules (Langfelder and
Horvath, 2008). Age-dependent modules were detected using an
unbiased approach, focusing only on modules whose representa-
tive expression pattern, the module’s eigengene (Langfelder and
Horvath, 2008), was signiﬁcantly correlated with age (a < 0.05) at
higher signiﬁcance levels than potentially confounding variables,
namely RIN, pH, and PMI. Only 1module fulﬁlled this criterion in all
3 data sets (Supplementary Tables 1e3) and showed strongsets and in the age-dependent module. (A) Overlap of genes from the 3 microarray gene
e Resource Center (HBTRC). (B) Demographics and coverage of the 3 data sets. (C) Venn
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the GO data base (Supplementary Table 4) for all the 3 data sets
used (Fig. 1C).
The module’s eigengene was negatively correlated with age at
lower p-values than with confounding variables in each data set
(Fig. 2 and Supplementary Fig. 1).
We validated the negative correlation between module eigen-
gene and age after matching samples for the confounding variables.
“Matched” in this context refers to the testing for correlation be-
tween the module eigengene and age just for those samples that
share the same value for the potentially confounding variable.
Supplementary Fig. 1 illustrates an example of Pearson’s correlation
coefﬁcients between module eigengene and age (in years) for
constant RIN values in the braincloud data. Clearly, for most of the
RIN values the negative correlation betweenmodule eigengene and
age (Fig. 2) is replicated (Supplementary Fig. 1). Similar results were
found for pH-values and when Spearman’s correlation was calcu-
lated instead of Pearson’s correlation. For simplicity, the following
analysis is described for the age-dependent module combined
across all 3 data sets. The “combined module” included n ¼ 426
genes that were expressed in at least 1 of the 3 data sets (Fig. 1C).
3.2. Microglia surface receptors’ expression levels reﬂect the age-
dependence of the module
To determine whether a speciﬁc cell type can explain this age-
dependent module, through variation of either its population sizeFig. 2. The age-dependent modules’ eigengene’s [gene relative expression: log2(sample/refe
the expression of all n ¼ 162 genes (x-axis) in the age-dependent module with age, derived
correlation of a given gene’s expression level with age. The red dashed line indicates the
correlation ¼ 0.35). (B) A negative slope of a linear model ﬁt with the age-dependent mo
pendent variable. (C) and (D) display the same metrics for the network derived from MRC
display the same metrics for the network derived from HBTRC data (n ¼ 326 genes in the a
MRC, Medical Research Council.or its gene expression repertoire, we sought known gene markers
that specify different CNS cell types (Butovsky et al., 2014; Cahoy
et al., 2008; David and Kroner, 2011; Forabosco et al., 2013)
(Supplementary Table 5). The module displayed a highly signiﬁcant
20-fold enrichment for microglial markers compared with random
gene sets of identical size (40 of 162 microglia markers, compared
with a median of 2 expected by chance, empirical p-value < 0.001);
moreover, it contained only 1 of the n ¼ 29 markers speciﬁc for
neurons, oligodendrocytes, endothelial cells, or astrocytes. The 3
data sets showed similar numbers of expressed microglia marker
genes in the age-dependent module. More speciﬁcally, about 10% of
genes were microglia markers in the “combined” module as well as
in the braincloud (n¼ 19 expressedmicrogliamarkers) and Harvard
brain tissue resource center (HBTRC) data sets (n ¼ 28 expressed
microglia markers), compared with a slightly higher number of
microglia marker genes in the module derived from the Medical
Research Council (MRC)/UK data set (about 20% microglia marker
genes [n ¼ 27] in the age-dependent module; see Supplementary
Tables 1e3 and 5). The module contained 4 of 6 gene markers
(P2RY12, GPR34, C1QA, and PROS1) that have been validated as being
expressed in human adult microglia but not in human blood-
derived monocytes (Butovsky et al., 2014). Importantly, the age-
dependent module contained a subset of these 4 markers in each
data set (P2RY12, GPR34, and C1QA in the MRC/UK data set, C1QA
and PROS1 in the HBTRC data set, and GPR34 and C1QA in the
braincloud data set). This “microglia module” thus principally re-
ﬂects gene expression variation across the human frontal cortex liference)] negative correlation with age. (A) Bar plot for Pearson’s correlation (y-axis) of
from braincloud data ranked by increasing correlations. Each bar reﬂects the Pearson’s
Pearson’s correlation for the age-dependent module’s eigengene with age (Pearson’s
dule’s eigengene’s expression as the dependent variable, and age [years] as the inde-
/UK data (n ¼ 141 genes in the age-dependent module); (E) and (F) correspondingly
ge-dependent module). Abbreviations: HBTRC, Harvard Brain Tissue Resource Center;
C.C. Wehrspaun et al. / Neurobiology of Aging 36 (2015) 2443.e9e2443.e202443.e14course in microglia, and not in other CNS cell types, and is not
derived from blood contamination.
We next considered whether the module contains genes that are
highly expressed in particular microglial subtypes, more speciﬁcally
62 genes that encode known markers for M1 or M2 phenotypes
(Supplementary Table 5). The combinedmicroglia module contained
marker genes predominantly for M1 or M1/M2b phenotypes. Never-
theless, these markers did not display a negative correlation with
aging (Fig. 3; Supplementary Fig. 2). To test whether the observed
independence of age was speciﬁc to the markers for microglia sub-
types that were assigned to the microglia module or true for all
available markers, we calculated the mean correlation between all
marker genes for a speciﬁc microglia subtype and age across the life
span for the MRC/UK and the braincloud data (Supplementary Figs. 3
and 4). Only markers speciﬁc for the anti-inﬂammatory phenotype
(M2a) showed a signiﬁcant decrease of gene expression in both data
sets across the life span (a< 0.05, uncorrectedp-values). Adecrease in
expression of M2a-markers, combined with relatively stable expres-
sionofM1markers, is in linewithprevious studies indicating a switch
from an M2- to M1-skewed microglial activation during aging
(Varnumand Ikezu, 2012). However, in contrast toM1markers,M2a-
markerswerenot assigned to the age-dependentmicrogliamodule in
both theMRC/UKand thebrainclouddata, butweredistributedacross
a relatively large number ofmodules. This indicates that expression ofFig. 3. Microglia surface receptors’ and microglia M1 and M1/M2b phenotype markers’ exp
data. The regression model ﬁt and conﬁdence interval for normalized gene expression versu
for neuron-microglia crosstalk (blue), (C) toll-like receptors (red), and (D) M1 and M1/M2b
normalized gene expression of the microglia module’s eigengene. Legends in (BeD) indicate
were included in the regression. Pearson’s correlation coefﬁcient of the mean expression of t
bottom-left corner of each plot.M2amarkers decreases during ageing, yet ismore stochastic than the
expression of genes assembled in the age-dependent microglia
module.
Microglia surface receptors for microglia-neuron crosstalk as
well as TLRs for communication with pathogen-associated molec-
ular patterns (Kierdorf and Prinz, 2013) tended to show a negative
correlation between gene expression level and age (Fig. 3;
Supplementary Fig. 2A). The importance of microglia surface re-
ceptors for communication between microglia and neurons is, for
example, reﬂected by CX3CR1’s nonredundant role for direct contact
with synapses and subsequent removal of synapses by phagocytosis
(Kierdorf and Prinz, 2013; Paolicelli et al., 2011) or TREM2’s effect on
autoimmune CNS demyelination (Kierdorf and Prinz, 2013;
Takahashi et al., 2007).
Our data are in line with previous observations of decreased
expression of the microglia-speciﬁc surface receptor CX3CR1 in the
aged brain (Harry, 2013; Wynne et al., 2010). This trend was less
pronounced, however, in the data for subjects aged50years and older
(HBTRC, Supplementary Fig. 2B), and was not observed when only
considering subjects 50 years and older in either MRC/UK or brain-
cloud data sets. This indicates that expression of these receptors de-
creases over the early adult life span but remains relatively constant
within the oldest age group. These gene expression time courses
indicate that the age-dependency of themicroglia module are drivenression correlation with age for Medical Research Council/United Kingdom (MRC/UK)
s age is for (A) the microglia module’s eigengene (shown in gray), (B) surface receptors
activational phenotype markers (green). The x-axis shows age and the y-axis shows
all respective marker genes that are expressed in the MRC/UK data set and therefore
he expressed marker genes (BeD) or module eigengene versus age (A) is shown in the
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of exogenous signals for microglia activation, especially in microglia-
neuron crosstalk (Kierdorf and Prinz, 2013; Saijo and Glass, 2011).3.3. A network of MRs controls the microglia module
To detect microglia-speciﬁc TFs in the healthy adult human
brain, which we shall refer to as MRs (Carro et al., 2010), TF targets
were predicted by reconstructing a transcriptional network using
ARACNE (Margolin et al., 2006a, 2006b). MRs for the microglia
module were identiﬁed based on signiﬁcant overlap of a TF’s pre-
dicted regulonwith themicroglia module ([FET], a< 0.05, corrected
for 1655 TFs in the ARACNE-derived transcriptional network).
Importantly, using this approach, TFs can be identiﬁed that are not
part of the microglia module themselves, for example, because they
function as upstream regulators. N ¼ 42, 23, and 64 MRs were
identiﬁed in the 3 data sets, resulting in n ¼ 107 MRs in all 3 sets
combined (Supplementary Table 6). Five MRseTAL1, PLEK, RUNX1,
IRF8, and ZFP36L2 e were replicated in all 3 data sets. Twelve more
were identiﬁed in at least 2 data sets (MAF, FLI1, KLF6, HHEX, LYL1,
PARP12, BNC2, PRDM4, IFI16, ELK3, FOS, and NFATC2).
The top-rankedMRs include TFs that are known to be expressed in
microglia (Kierdorf et al., 2013; Smith et al., 2013) and act in experi-
mentally validated interactions. For example, RUNX1 and PU.1 (that
was top-ranked in the MRC/UK data but not replicated) form a
negative feedback loop for regulating PU.1 transcript abundance and
subsequently regulate myeloid cell fate (Jin et al., 2012; Kierdorf and
Prinz, 2013), and PU.1 and IRF8 function as interaction partners in
microglia (Kierdorf et al., 2013). RUNX1 also directly interacts with
TAL1 and FLI1 (Lichtinger et al., 2012), whereby PU.1 in turnmediates
TAL1 activity (Le Clech et al., 2006). The interdependence among the
MRs is further illustrated by the strongoverlap of their regulons (Fig. 4
and Supplementary Fig. 5). Almost all predicted target genes that are
regulated by at least 2 of theMRs RUNX1, PU.1, and IRF8 belong to the
microglia module (Fig. 4). More speciﬁcally, all 14 genes that are
regulated by all 3MRs, RUNX1, PU.1 and IRF8, belong to themicroglia
module (Fig. 4A). This is in contrast to most of the genes that are
regulated by only 1 of these 3 regulators which tend not to be mem-
bers of the microglia module (Fig. 4B). In addition to the trivial GO-
enrichment for regulatory functions of TFs, 107 MRs were also
signiﬁcantly enriched in KEGG-pathways “Acute myeloid leukaemia”
(p-value¼ 2.5103, Bonferroni corrected) and “Pathways in cancer”Fig. 4. Overlap of MR’s (RUNX1, PU.1, and IRF8) predicted target genes in the microglia modu
Kingdom [MRC/UK]) (B). (A) Predicted regulons (in other words target genes) of RUNX1, PU.1
the microglia module. (B) As in (A) but including all predicted target genes of the 3 MRs acro
are present in both (A) and (B). Supplementary Fig. 5 shows the same gene sets as in this(p-value ¼ 6.9  103, Bonferroni corrected) terms. These ﬁndings
likely reﬂect their crucial roles inmyeloid and hematopoietic cell-fate
decisions (Lichtinger et al., 2012).
Next we asked whether transcriptional level interactions, as
derived above via network analysis, are also manifested on the
protein level. We tested whether the 107 MRs engage in known
protein-protein interactions. For this, we used DAPPLE to search for
signiﬁcant physical connectivity, based on protein-protein in-
teractions that have been reported in the literature (Fig. 5) (Rossin
et al., 2011). DAPPLE assesses the signiﬁcance of interactions in the
input gene sets based on node-label permutations, as described in
the Section 2 (Rossin et al., 2011). We found that 40 of 107 MRs
reached a corrected p-value < 0.05 (Supplementary Table 7),
including 3 of the 5MRs thatwere replicated in every data set (TAL1,
RUNX1, IRF8) and the top-rankedMR in theMRC/UK data set (PU.1).
Protein-proteinnetwork statisticswerehighly signiﬁcant, showinga
higher number of direct connections betweenMRs than expected by
chance (n ¼ 48 direct interactions between 36 proteins in direct
network,p-value<0.001), higher averagedirect connectivity ofMRs
(or direct binding degree; mean ¼ 2.7, p-value < 0.001), as well as
indirect connectivity (mean ¼ 50.7, p-value < 0.001). The protein-
protein interaction network derived by DAPPLE indicates that in-
teractions between theMRs of the microglia module act not only on
the transcriptional but also on the protein level.3.4. ChIP-Seq data indicate causal roles of MRs for the microglia
module
The predicted target genes of theMRs could reﬂect either indirect
(noncausal) co-ordination among genes in the transcriptional
network, or direct (causal) interactions of TFs and their target genes.
To distinguish between these possibilities, we veriﬁed that the MRs’
targets in the microglia module predicted by ARACNE were causal
using publicly available ChIP-Seq data for RUNX1, IRF8, and TAL1, TFs
that were replicated in all 3 data sets, and PU.1, which was top-
ranked in the MRC/UK set, but not replicated (Fig. 6). For each of
the 4 MRs, we tested for signiﬁcant overlap between their binding
sites as indicated by their ChIP-Seq peaks, and the basal regulatory
domains [5kb upstream and 1kb downstream of each gene’s TSS
(McLean et al., 2010)] of their predicted target genes in the combined
microglia module (n ¼ 407 basic regulatory domains available in
ENSEMBL BioMart). The overlap between ChIP-Seq peaks and thele (A) compared with genes from the whole data set (Medical Research Council/United
, and IRF8 in the MRC/UK gene expression data. (A) displays only genes that are part of
ss all genes in the network. It is of note that n ¼ 14 genes that are regulated by all 3 MRs
ﬁgure including all gene names.
Fig. 5. Protein-protein interactions are recapitulated in a MR (MR) network. A protein-protein network, derived from direct and indirect interactions among proteins encoded by
MRs’ genes. Colors represent Disease Association Protein-Protein Link Evaluator p-values (see legend), calculated from 1000 within-degree node-label permutations. The network
was constructed on the basis of physical protein-protein interactions that have been reported in the literature (Rossin et al., 2011). For simplicity, only names for proteins with the
most signiﬁcant interactions are displayed; for the complete set see Supplementary Table 7.
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19,045 basal regulatory domains of all genes available in ENSEMBL
BioMart and expressed in at least 1 of the 3 microarray gene
expression data sets. As a negative control, we tested for overlap
between ChIP-Seq peaks of a randomly chosen TF which was not
identiﬁed as a MR (NANOG) and basal regulatory domains of all
expressed genes from the combined microglia module.
PU.1 is known to bind near the promoter regions of its target
genes (Pruitt et al., 2005). ChIP-Seq peaks for PU.1 binding anno-
tated within TSS-promoter regions in 3 available cell lines from the
ENCODE data (GM12878, GM12891, and K562) (Birney et al., 2007)
showed signiﬁcant overlap with the genes in the combined
microglia module (Fig. 6A; all signiﬁcant p-values < 0.002) in each
of the 3 cell lines. Enrichment of PU.1 binding sites in the combined
microglia module validates PU.1 as a correctly identiﬁed MR
although it was only detected in 1 data set, and is in line with
previous studies (Satoh et al., 2014). Correspondingly, ChIP-Seq
peaks for RUNX1, IRF8, and TAL1 indicated signiﬁcant overlap of
these MRs’ binding sites with the basal regulatory domains of the
genes in the combined microglia module (Fig. 6). In contrast, ChIP-
Seq peaks for a randomly chosen TF (NANOG), which was not
identiﬁed as a MR, did not signiﬁcantly overlap with the basal
regulatory domains of the genes in the combined microglia module
(p-value > 0.05). For the cell lines which had gene expression data
available, namely the cell lines provided by the ENCODE data,analyses were repeated and similar results were found after the
brain-expressed genes from the human postmortem data were
restricted to the genes whose expression was supported by at least
1 sequencing read in the respective cell line.
The signiﬁcant overlap of TF binding sites as detected by ChIP-
Seq and the combined microglia module indicates a causal role
for the identiﬁed hematopoietic MRs in the expression of their
target genes. As assembly of the microglia module as well as pre-
diction of microglia-speciﬁc MRs were founded upon gene
expression changes across the human adult life span, the present
data show that each of the identiﬁed MRs plays a key role in
microglia homeostasis not only during embryogenesis but also in
the aging brain.
4. Discussion
Regulation of microglia homeostasis in the healthy adult human
brain is poorly understood (Kierdorf and Prinz, 2013). Previous
studies have elucidated how microglia emerge from the yolk sac
during embryogenesis, and are dependent on the orchestrated
functions of TFs, including RUNX1, PU.1, and IRF8 (Ginhoux et al.,
2010; Kierdorf et al., 2013). In response to insult or injury, micro-
glia maintain the ability to self-renew (Ajami et al., 2007) or
monocytes may be recruited to differentiate into microglia from the
bonemarrow (Lampron et al., 2011; Ponomarev et al., 2013). Studies
Fig. 6. ChIP-Seq peaks for SPI1 (PU.1), RUNX1, IRF8, and TAL1 near to genes in the combined microglia module. (A) Fold enrichment for SPI1 (PU.1), RUNX1, IRF8, and TAL1 ChIP-Seq
peaks in all annotated basal regulatory domains of all genes in the combined microglia module (n ¼ 407 assigned to the microglia module in all 3 data sets combined). Asterisks
denote a signiﬁcant (p-value < 0.05) enrichment. The legend indicates the cell lines that were used for each MR. (B) Illustration of MR binding sites overlapping the basal regulatory
domain of AIF1 (taken from the UCSC genome browser).
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provided evidence that key TFs are also necessary for regulating the
transition between microglia activational phenotypes, speciﬁcally
for the transition between proinﬂammatory (M1) and anti-
inﬂammatory (M2) states (Jin et al., 2012; Kierdorf and Prinz,
2013; Parakalan et al., 2012; Zusso et al., 2012). However, it re-
mains unclear what role these key regulators play in the homeo-
stasis of microglia in the healthy adult human brain (Kierdorf and
Prinz, 2013).
Here we have shown that a gene coexpression module, which is
highly enriched for microglia markers (predominantly for M1 and
M2b phenotypes), is controlled by a network of MRs that also act as
key players during hematopoiesis and myeloid cell lineage deter-
mination. The microglia module was identiﬁed in 3 independent
data sets based on the negative correlation of gene expression with
aging and contained genes encoding receptors for exogenous sig-
nals for microglia activation: CX3CR1 transmits “resting” signals,
TREM2 and TYROBP initiate phagocytosis, purinergic receptors
(P2RY12, P2RY13, P2RY6, P2RY5) signal neuronal injury and CSF1R
induces cell survival or proliferation (Kierdorf and Prinz, 2013).
More speciﬁcally, the expression levels of genes encoding microglia
surface receptors for microglia-neuron crosstalk or TLRs were
negatively correlated with increasing age. The predicted MRs were
not all members of the microglia module, and included subsets of
endogenous TFs (e.g., RUNX1, PU.1, and IRF8) that are known to
regulate microglia activation (Kierdorf and Prinz, 2013), and are
required for differentiation during embryonic development
(Kierdorf et al., 2013; Lichtinger et al., 2012). These TFs act
co-ordinately with highly overlapping binding sites. For example,
an IRF8 and PU.1 heterodimer exhibits stronger binding activity
than IRF8 alone (Kubosaki et al., 2010; Shin et al., 2011).Importantly, our analysis demonstrates that interacting hemato-
poietic MRs from early development are recapitulated within adult
human brain tissue. This indicates that a number of the key factors
acting during early microglia developmentdincluding RUNX1, PU.1
and IRF8dalso play crucial roles in adult microglia homeostasis.
Previous work has provided evidence for a cohesive immune-
microglia module that is evident in human brain transcriptomes.
These studies compared the transcriptomes of different neuroan-
atomical subdivisions (Forabosco et al., 2013; Hawrylycz et al.,
2012; Oldham et al., 2008; Zhang et al., 2013), or searched for
candidate genes for susceptibility to neurodegenerative disease
(Forabosco et al., 2013; Zhang et al., 2013). For example, TREM2 is a
predisposing factor for late-onset Alzheimer’s disease (Forabosco
et al., 2013) and was also present in the microglia module in all 3
data sets in the present study. However, although TREM2 showed
highly signiﬁcant module membership, in other words correlation
with the module eigengene, it was not ranked in the top 10% of
microglia module genes with highest module membership across
the 3 data sets and thus would not have been selected as a central
hub gene in an objective, data-driven approach. It has to be noted,
however, that we ﬁnd that it is not a central hub from frontal cortex
data, whereas TREM2 was identiﬁed in previous work as a major
hub in different brain regions (Forabosco et al., 2013; Jiang et al.,
2014) with increased expression in a subset of these regions dur-
ing aging (Forabosco et al., 2013; Jiang et al., 2014). Furthermore,
previous studies investigating various areas in human postmortem
brains from 55 subjects aged 20e99 years (hippocampus, entorhi-
nal cortex, superior-frontal gyrus, and postcentral gyrus) reported
the upregulation of genes related to inﬂammation and immune
components (Berchtold et al., 2008; Cribbs et al., 2012). Along these
lines, despite general consensus that the number of microglia does
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reported microglia becoming more numerous in distinct brain re-
gions during normal aging, namely cortical sensory areas (Tremblay
et al., 2012). These results could indicate a regional speciﬁcity for
immune-related transcriptional regulation in the adult human
brain. Further studies focused on comparing transcriptomes from
various postmortem brain areas, yet these were derived from both
healthy controls and disease cases. In one of these studies, TYROBP
was identiﬁed as a key regulator for an immune- and microglia-
speciﬁc transcriptional network, that was differentially expressed
between control and late-onset Alzheimer’s disease postmortem
brains, highlighting its potential role in disease status (Zhang et al.,
2013).
Changes in transcript abundance can be caused by changes in
transcription rate in the cell, or by changes in relative or absolute
cell numbers of a speciﬁc cell type (Ponting and Oliver, 2012).
Previous lines of work have shown thatdalthough the relative
number of glia cells compared with neurons increases with age
(Terry et al., 1987)dthe cell number of microglia stays stable during
the adult life time (Norden and Godbout, 2013; VanGuilder et al.,
2011). Furthermore, as the microglia module predominantly con-
tained markers for the proinﬂammatory (M1) phenotype, a
decrease in expression during aging cannot simply be explained by
a shift toward a proinﬂammatory phenotype during aging (Lee
et al., 2013; Schuitemaker et al., 2012).
An alternative explanation for the observed decrease in
expression levels of the microglia module is a lower rate of tran-
scription for genes that regulate microglia activation. It has been
observed, for example, in the present and in previous studies
(Harry, 2013; Wynne et al., 2010), that expression of receptor
CX3CR1 is diminished in the aged brain. Along these lines
morphological changes in microglia during older age (Conde and
Streit, 2006; Hefendehl et al., 2014; Streit et al., 2004) potentially
reﬂect dystrophy and cellular senescence rather than increased
activation, which could explain a downregulation of endogenous
receptor levels including for CX3CR1 (Harry, 2013).
The microglia module in adult human brains recapitulates MRs
for microglia development during embryogenesis (Kierdorf and
Prinz, 2013). This indicates that the identiﬁed MRs maintain a
causal role for microglia homeostasis during aging. One possible
role the MRs could fulﬁl for microglia in adult brains is regulation of
replicative senescence. For example, given PU.1’s role in preventing
excessive hematopoietic stem cell division (Staber et al., 2013), this
known MR for early microglia development may also mediate
microglia replicative senescence in normal aging. Accordingly, TAL1
is directly linked to cell growth rates (Dey et al., 2010). In line with
this basic notion, microglia senescence during aging (Streit et al.,
2008) and expression levels of PU.1 (Furukawa et al., 2004),
RUNX1 (Adamo et al., 2009), and TAL1 (Wang et al., 2006) are all
affected by stress (Furukawa et al., 2004). Therefore, although PU.1
sustains its levels via autoregulation (Staber et al., 2013), it could
prevent excessive proliferation of M1 microglia in response to
accumulating oxidative stress during aging in co-ordination with
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